acetylcysteine has been researched along with Blood Poisoning in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.79) | 18.7374 |
1990's | 6 (10.71) | 18.2507 |
2000's | 17 (30.36) | 29.6817 |
2010's | 25 (44.64) | 24.3611 |
2020's | 7 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Geng, Y; Liang, H; Liu, J; Liu, S; Ouyang, J; Peng, N; Su, L; Tang, Y; Wan, Y; Wang, JH; Yu, B; Yuan, F | 1 |
Bagio, E; Barichello, T; Bonfante, SRSA; de Carli, RJ; de Oliveira Junior, AN; de Oliveira, MP; Della Giustina, A; Dos Santos, TM; Engel, NA; Goldim, MPS; Joaquim, L; Kanis, LA; Metzker, KLL; Muttini, S; Novochadlo, M; Petronilho, F; Rezin, GT; Tenfen, L | 1 |
Constantino, L; Dal-Pizzol, F; Damásio, D; Fraga, C; Gonçalves, RC; Michels, M; Ritter, C | 1 |
Fan, H; Le, JW; Zhu, JH | 1 |
Basile, K; Colaco, CMG; Draper, J; Ferguson, PE | 1 |
Dou, Q; Gan, H; Tong, H; Yang, Y; Zhang, H | 1 |
Bedreag, OH; Bratu, LM; Bratu, T; Cradigati, CA; Dinu, A; Papurica, M; Popovici, SE; Rogobete, AF; Sandesc, D; Sandesc, M; Sarandan, M; Stan, AT | 1 |
Levi, M; Scully, M; Singer, M | 1 |
Ganaes, JOF; Lopes-Pires, ME; Naime, ACA | 1 |
Boroumand, N; Hashemy, SI; Peivandi Yazdi, A; Razavi, M; Salehi, M; Sheikh, S | 1 |
Cate, SA; Chen, J; Dominguez, M; Fu, X; Konkle, BA; López, JA; Osborn, W; Özpolat, T | 1 |
Amathieu, R; Chemit, M; Compagnon, P; Costentin, C; Dhonneur, G; Levesque, E; Merle, JC | 1 |
Visvanathan, V | 1 |
Dal-Pizzol, F; de Castro, AA; Quevedo, J; Steckert, AV | 1 |
Fu, J; Ji, K; Li, G; Luan, T; Zang, B; Zhao, Y | 1 |
Abdollahi, M; Ahmadi, A; Ahmadi, KH; Chelkeba, L; Mojtahedzadeh, M; Mousavi, M; Najafi, A; Najmeddin, F | 1 |
Barbosa de Castro, CM; Dornelas de Andrade, AF; Filho, CA; Galvão, AM; Melo-Junior, MR; Silva, LA; Silva, RA; Souza Maia, MB; Streck, EL; Wanderley, MS | 1 |
Chao, J; Chao, L; Chen, CW; Huang, YW; Lin, CF; Lin, WC; Lin, YS | 1 |
Bedreag, OH; Cradigati, CA; Dumache, R; Horhat, FG; Luca, L; Papurica, M; Popovici, SE; Rogobete, AF; Sandesc, D; Sarandan, M; Sima, LV; Vernic, C | 1 |
Chertoff, J | 1 |
Hou, L; Ji, G; Li, N; Li, S; Lu, Y; Ma, S; Peng, D; Qin, M; Shang, L; Xie, K; Xiong, L | 1 |
Rajapakse, S; Wijewickrama, ES | 1 |
Andrades, M; Dal-Pizzol, F; de Oliveira, MR; Fonseca Moreira, JC; Ritter, C; Streck, EL | 1 |
Cassol, OJ; Dal-Pizzol, F; Ferreira, GK; Gonçalves, CL; Petronilho, FC; Rezin, GT; Roesler, R; Scaini, G; Schwartsmann, G; Streck, EL | 1 |
Buaes, LE; Caberlon, E; Christ Vianna Santos, R; da Costa, VL; da Silva Melo, DA; da Silva Scherer, P; da Silva, GV; de Mello, RO; de Moraes, CM; de Oliveira, JR; Donadio, MV; Lunardelli, A; Nunes, FB | 1 |
Marsh, A; Myall, K; Sidney, J | 1 |
Sahoo, RK; Sharma, A | 1 |
Antunes, E; Casarin, AL; Lopes-Pires, ME; Lorand-Metze, I; Marcondes, S; Pereira-Cunha, FG | 1 |
Ayan, M; Cander, B; Erayman, I; Erdem, S; Girişgin, S; Gül, M; Seydanoğlu, A | 1 |
García, C; Martínez, M; Nicolás, M; Porta, R; Sánchez, L | 1 |
Andrade, L; Campos, R; Canale, D; de Bragança, AC; Lopes, FD; Olivo, C; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
Eisenhut, M | 1 |
Hauser, B; Radermacher, P; Szakmany, T | 1 |
Buwalda, M; Ince, C | 1 |
Galley, HF; Paterson, RL; Webster, NR | 1 |
Pinsky, MR | 1 |
Crouser, ED | 1 |
Andrades, M; Dal-Pizzol, F; Moreira, JC; Ritter, C | 1 |
Spapen, H | 1 |
Emet, S; Memis, D; Pamukçu, Z | 1 |
Diltoer, MW; Hendrickx, I; Huyghens, LP; Nguyen, DN; Spapen, HD | 1 |
Barreiro, E; Gáldiz, JB; Gea, J; Hussain, SN; Sánchez, D | 1 |
Atis, S; Bagdatoglu, O; Comelekoglu, U; Gunes, S; Nayci, A; Ozge, A | 1 |
Cross, CE; Halliwell, B; van Asbeck, BS | 1 |
Demiralay, R; Erdem, H; Gürsan, N | 1 |
Andrades, M; Bernard, EA; Dal-Pizzol, F; de Souza, LF; Moreira, JC; Pens Gelain, D; Ritter, C | 1 |
Kapiotis, S; Mittermayer, F; Pleiner, J; Posch, M; Schaller, G; Wolzt, M | 1 |
Barichello, T; Constantino, L; Dal-Pizzol, F; Machado, RA; Martins, MR; Petronilho, F; Quevedo, J; Réus, GZ; Ritter, C; Valvassori, SS | 1 |
Ghezzi, P; Villa, P | 1 |
Benlabed, M; Buurman, WA; Nguyen, DN; Spapen, H; Vincent, JL; Zhang, H | 1 |
Blackwell, TR; Blackwell, TS; Christman, BW; Christman, JW; Holden, EP | 1 |
Bernard, GR; Weikert, LF | 1 |
Fischer, JE; Hasselgren, PO; Hobler, SC; Monaco, J; Tiao, G | 1 |
Caputi, AP; Costantino, G; Cuzzocrea, S | 1 |
Ghezzi, P; Saccani, A; Sica, A; Villa, P | 1 |
Broner, CW; Hildner, WK; Shenep, JL; Stidham, GL; Stokes, DC | 1 |
11 review(s) available for acetylcysteine and Blood Poisoning
Article | Year |
---|---|
The role of ADAMTS-13 in the coagulopathy of sepsis.
Topics: Acetylcysteine; ADAMTS13 Protein; Animals; Blood Coagulation; Humans; Recombinant Proteins; Sepsis; Substrate Specificity; Thrombotic Microangiopathies; von Willebrand Factor | 2018 |
Sepsis: The Involvement of Platelets and the Current Treatments.
Topics: Acetylcysteine; Animals; Blood Platelets; Capsaicin; Chloroquine; Disseminated Intravascular Coagulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-7; Platelet Aggregation Inhibitors; Sepsis; Software; Thrombocytopenia; Toll-Like Receptor 4 | 2018 |
[Severe toxic acute liver failure: etiology and treatment].
Topics: Acetaminophen; Acetylcysteine; Acute Kidney Injury; Anti-Infective Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Cholestasis; Combined Modality Therapy; Diagnosis, Differential; Disease Management; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Illicit Drugs; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Mushroom Poisoning; Neurologic Examination; Occupational Diseases; Respiratory Insufficiency; Sepsis; Shock; Time Factors; Valproic Acid | 2013 |
Sepsis in the central nervous system and antioxidant strategies with N-acetylcysteine, vitamins and statins.
Topics: Acetylcysteine; Animals; Antioxidants; Central Nervous System; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Sepsis; Vitamins | 2014 |
N-Acetylcysteine's Role in Sepsis and Potential Benefit in Patients With Microcirculatory Derangements.
Topics: Acetylcysteine; Acidosis, Lactic; Free Radical Scavengers; Humans; Microcirculation; Mortality; Multiple Organ Failure; Regional Blood Flow; Sepsis; Vasodilation | 2018 |
Non-dialytic management of sepsis-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Contrast Media; Dopamine; Evidence-Based Medicine; Fluid Therapy; Humans; Hypoglycemic Agents; Insulin; Kidney Diseases; Osmotic Pressure; Perfusion; Risk Assessment; Risk Factors; Sepsis; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Lack of toxicity after paracetamol overdose in a extremely preterm neonate.
Topics: Abdominal Pain; Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Chemical and Drug Induced Liver Injury; Drug Overdose; Female; Free Radical Scavengers; Half-Life; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Medication Errors; Metabolic Clearance Rate; Sepsis; Treatment Outcome | 2012 |
N-acetylcysteine for sepsis and systemic inflammatory response in adults.
Topics: Acetylcysteine; Adult; Antioxidants; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Sepsis; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Opening the microcirculation: can vasodilators be useful in sepsis?
Topics: Acetylcysteine; Animals; Epoprostenol; Hemodynamics; Humans; Microcirculation; Netherlands; Nitric Oxide Donors; Oxygen; Pentoxifylline; Sepsis; Treatment Outcome; Vasodilator Agents | 2002 |
Antioxidant therapy for severe sepsis: promise and perspective.
Topics: Acetylcysteine; Antioxidants; Humans; NF-kappa B; Reproducibility of Results; Sepsis | 2003 |
Pharmacotherapy of sepsis.
Topics: Acetylcysteine; Antioxidants; Bradykinin; Cyclooxygenase Inhibitors; Humans; Naloxone; Pentoxifylline; Platelet Activating Factor; Sepsis | 1996 |
6 trial(s) available for acetylcysteine and Blood Poisoning
Article | Year |
---|---|
Clinical Trial Assessment of Intermittent and Continuous Infusion Dose of N-Acetylcysteine on Redox Status of the Body in Patients with Sepsis Admitted to the ICU.
Topics: Acetylcysteine; Humans; Infusions, Intravenous; Intensive Care Units; Oxidation-Reduction; Prospective Studies; Sepsis | 2020 |
The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients.
Topics: Acetylcysteine; Adult; Antioxidants; APACHE; beta-Defensins; Creatinine; Critical Illness; Female; Glutathione; Humans; Immunoglobulin M; Intensive Care Units; Leukocyte Count; Male; Middle Aged; Multiple Trauma; Organ Dysfunction Scores; Respiration, Artificial; Sepsis; Young Adult | 2014 |
The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Free Radical Scavengers; Humans; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Male; Middle Aged; NF-kappa B; Sepsis | 2003 |
The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Cytokines; Double-Blind Method; Female; Gastric Mucosa; Hemodynamics; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Monitoring, Physiologic; Oxidative Stress; Oxygen Consumption; Sepsis; Severity of Illness Index; Statistics, Nonparametric | 2004 |
Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study.
Topics: Acetylcysteine; Acute Disease; Adult; Aged; Aged, 80 and over; Albuminuria; Female; Humans; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Severity of Illness Index | 2005 |
Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans.
Topics: Acetylcysteine; Adult; Blood Circulation; Cross-Over Studies; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Free Radical Scavengers; Humans; Infusions, Intravenous; Interleukin-1beta; Lipopolysaccharides; Male; Oxidative Stress; Renal Circulation; Sepsis; Tumor Necrosis Factor-alpha | 2007 |
39 other study(ies) available for acetylcysteine and Blood Poisoning
Article | Year |
---|---|
Endothelial glycocalyx injury is involved in heatstroke-associated coagulopathy and protected by N-acetylcysteine.
Topics: Acetylcysteine; Animals; Blood Coagulation Disorders; Endothelial Cells; Glycocalyx; Heat Stroke; Hydrogen Peroxide; Rats; Reactive Oxygen Species; Retrospective Studies; Sepsis | 2023 |
Gold nanoparticles potentiates N-acetylcysteine effects on neurochemicals alterations in rats after polymicrobial sepsis.
Topics: Acetylcysteine; Animals; Antioxidants; Cytokines; Disease Models, Animal; Gold; Hippocampus; Inflammation; Male; Metal Nanoparticles; Mitochondria; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Sepsis | 2020 |
Stratification to predict the response to antioxidant.
Topics: Acetylcysteine; Adult; Aged; Animals; Antioxidants; Deferoxamine; Humans; Male; Middle Aged; Prognosis; Rats; Rats, Wistar; Retrospective Studies; Sepsis; Treatment Outcome | 2020 |
Protective Effect of N-Acetylcysteine Pretreatment on Acute Kidney Injury in Septic Rats.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cecum; Disease Models, Animal; Kidney; Ligation; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Sepsis | 2020 |
Fulminant
Topics: Acetylcysteine; Acidosis; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacillus cereus; Blood Coagulation Disorders; Blood Transfusion; Brain Diseases; Continuous Renal Replacement Therapy; Exotoxins; Fatal Outcome; Female; Foodborne Diseases; Free Radical Scavengers; Humans; Immunocompetence; Liver Failure; Multiple Organ Failure; Plasmapheresis; Renal Insufficiency; Rhabdomyolysis; Sepsis; Shock; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing | 2021 |
PICK1 Deficiency Exacerbates Sepsis-Associated Acute Kidney Injury.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line; Disease Models, Animal; Epithelial Cells; Humans; Kidney Tubules, Proximal; Lipopolysaccharides; Male; MAP Kinase Kinase Kinase 5; Mice, Inbred C57BL; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Peroxides; Sepsis | 2021 |
Analysis of oxidative stress-related markers in critically ill polytrauma patients: An observational prospective single-center study.
Topics: Acetylcysteine; Adult; Antioxidants; APACHE; Ascorbic Acid; Biomarkers; Critical Care; Critical Illness; Female; Humans; Inflammation; Lipid Peroxidation; Lipids; Male; Middle Aged; Multiple Trauma; Oxidative Stress; Partial Thromboplastin Time; Prospective Studies; Sepsis; Treatment Outcome | 2018 |
Cysteine Disulfides (Cys-ss-X) as Sensitive Plasma Biomarkers of Oxidative Stress.
Topics: Acetylcysteine; Anemia, Sickle Cell; Antioxidants; Biomarkers; Cysteine; Disulfides; Humans; Oxidative Stress; Sepsis | 2019 |
N-acetylcysteine for sepsis and systemic inflammatory response in adults.
Topics: Acetylcysteine; Critical Care; Humans; Sepsis; Systemic Inflammatory Response Syndrome | 2013 |
Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Survival; Cyclooxygenase 2; Dinoprostone; I-kappa B Kinase; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mesangial Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Rats; Sepsis; Signal Transduction; Thioctic Acid; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |
Intratracheal co-administration of antioxidants and ceftriaxone reduces pulmonary injury and mortality rate in an experimental model of sepsis.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Ceftriaxone; Disease Models, Animal; Drug Administration Routes; Drug Therapy, Combination; Lung Injury; Male; Rats; Rats, Wistar; Sepsis; Trachea; Vitamin E | 2014 |
Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Down-Regulation; Epithelial Cells; Fas Ligand Protein; fas Receptor; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; NF-kappa B; Reactive Oxygen Species; Respiratory Distress Syndrome; Sepsis; Serpins; Signal Transduction | 2015 |
Modulation of the Redox Expression and Inflammation Response in the Critically Ill Polytrauma Patient with Thoracic Injury. Statistical Correlations between Antioxidant Therapy.
Topics: Abbreviated Injury Scale; Acetylcysteine; Adult; Aged; Antioxidants; Ascorbic Acid; Critical Illness; Female; Humans; Incidence; Inflammation; Injury Severity Score; Length of Stay; Male; Middle Aged; Multiple Organ Failure; Multiple Trauma; Oxidation-Reduction; Oxidative Stress; Respiration, Artificial; Retrospective Studies; Sepsis; Thiamine; Thoracic Injuries | 2016 |
Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cytokines; Free Radical Scavengers; Heart; Inflammation; Kidney; Liver; Lung; Male; Mice; Multiple Organ Failure; Myocardium; Oxygen; Reactive Oxygen Species; Sepsis; Thiourea; Zymosan | 2010 |
Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Deferoxamine; Disease Models, Animal; Kidney; Lung; Male; Multiple Organ Failure; Neutrophil Infiltration; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Urea | 2011 |
Effects of N-acetylcysteine/deferoxamine, taurine and RC-3095 on respiratory chain complexes and creatine kinase activities in rat brain after sepsis.
Topics: Acetylcysteine; Animals; Bombesin; Brain; Creatine Kinase; Deferoxamine; Electron Transport; Male; Peptide Fragments; Rats; Rats, Wistar; Sepsis; Taurine | 2010 |
Effect of N-acetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis.
Topics: Acetylcysteine; Animals; Drug Synergism; Drug Therapy, Combination; Fructose-Bisphosphatase; Rats; Sepsis; Survival Rate; Treatment Outcome | 2011 |
Mind the gap! An unusual metabolic acidosis.
Topics: Acetaminophen; Acetylcysteine; Acidosis; Anti-Bacterial Agents; Antioxidants; Female; Floxacillin; Humans; Middle Aged; Pyrrolidonecarboxylic Acid; Sepsis; Sodium Bicarbonate | 2011 |
Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Epirubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Young Adult | 2011 |
Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.
Topics: Acetylcysteine; Adenosine Diphosphate; Animals; Blood Platelets; Free Radical Scavengers; Lipopolysaccharides; Male; Oxidation-Reduction; Platelet Aggregation; Rats; Rats, Wistar; Reactive Oxygen Species; Sepsis; Time Factors | 2012 |
The effect of N-acetyl cysteine on serum glutathione, TNF-alpha and tissue malondialdehyde levels in the treatment of sepsis.
Topics: Acetylcysteine; Animals; Female; Free Radical Scavengers; Glutathione; Malondialdehyde; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sepsis; Tumor Necrosis Factor-alpha | 2011 |
N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Cecum; Disease Models, Animal; Glomerular Filtration Rate; Kidney; Lung; Male; Neutrophils; Oxidative Stress; Pulmonary Edema; Rats; Rats, Wistar; Respiration, Artificial; Sepsis; Sodium Channels; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2012 |
Role of nitric oxide metabolites in reduction of sodium potassium ATPase dependent pulmonary edema clearance.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Male; Pulmonary Edema; Respiration, Artificial; Sepsis | 2012 |
Therapeutic benefits of antioxidants during sepsis: is protection against oxidant-mediated tissue damage only half the story?
Topics: Acetylcysteine; Animals; Antioxidants; Deferoxamine; Free Radical Scavengers; Humans; Iron Chelating Agents; Oxidative Stress; Sepsis | 2004 |
Antioxidants and sepsis: can we find the ideal approach?
Topics: Acetylcysteine; Animals; Antioxidants; Humans; Iron; Sepsis; Swine | 2004 |
N-acetylcysteine in clinical sepsis: a difficult marriage.
Topics: Acetylcysteine; Cytokines; Gastric Mucosa; Humans; Intensive Care Units; Oxidative Stress; Oxygen Consumption; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic | 2004 |
N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms.
Topics: Acetylcysteine; Analysis of Variance; Animals; Biopsy, Needle; Diaphragm; Disease Models, Animal; Immunohistochemistry; Male; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Sensitivity and Specificity; Sepsis; Superoxide Dismutase | 2005 |
N-acetylcysteine protects the rats against phrenic nerve dysfunction in sepsis.
Topics: Acetylcysteine; Animals; Catalase; Electromyography; Malondialdehyde; Nitrates; Nitrites; Oxidation-Reduction; Oxidative Stress; Peroxidase; Phrenic Nerve; Rats; Rats, Wistar; Sepsis | 2006 |
More antioxidants in sepsis: still paved with uncertainties.
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Deferoxamine; Disease Models, Animal; Humans; Oxidation-Reduction; Oxidative Stress; Respiratory Distress Syndrome; Sepsis; Siderophores | 2006 |
Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine.
Topics: Acetylcysteine; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Epithelial Cells; Free Radical Scavengers; Immunohistochemistry; In Situ Nick-End Labeling; Lipopolysaccharides; Lung; Peroxidase; Pneumonia; Rats; Rats, Wistar; Sepsis; Thioglycolates; Thiophenes; Tissue Embedding; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2006 |
Mitochondrial superoxide production is related to the control of cytokine release from peritoneal macrophage after antioxidant treatment in septic rats.
Topics: Acetylcysteine; Animals; Antioxidants; Cytokines; Deferoxamine; Macrophages, Peritoneal; Male; Mitochondria; Rats; Rats, Wistar; Sepsis; Signal Transduction; Superoxides; Thiobarbituric Acid Reactive Substances | 2007 |
Antioxidant treatment prevented late memory impairment in an animal model of sepsis.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Cecum; Deferoxamine; Disease Models, Animal; Habituation, Psychophysiologic; Intestinal Perforation; Ligation; Male; Memory Disorders; Rats; Rats, Wistar; Sepsis | 2007 |
Effect of N-acetyl-L-cysteine on sepsis in mice.
Topics: Acetylcysteine; Allopurinol; Animals; Cecum; Free Radical Scavengers; Free Radicals; Glutathione; Liver; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Oxidative Stress; Sepsis; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 1995 |
Protective effects of N-acetyl-L-cysteine in endotoxemia.
Topics: Acetylcysteine; Animals; Blood Pressure; Cardiac Tamponade; Dogs; Endotoxins; Escherichia coli; Female; Heart Rate; Hematocrit; Hemodynamics; Lactates; Male; Oxygen Consumption; Pulmonary Artery; Pulmonary Circulation; Sepsis; Stroke Volume; Time Factors; Vascular Resistance; Ventricular Function, Left; Ventricular Function, Right | 1994 |
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Base Sequence; Chemokines, CXC; Chemotactic Factors; Chemotaxis, Leukocyte; Dinoprost; Disease Models, Animal; Drug Evaluation, Preclinical; Endotoxins; F2-Isoprostanes; Gene Expression Regulation; Glutathione; Growth Substances; Inflammation; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Lung; Lung Diseases; Male; Molecular Sequence Data; Neutrophils; NF-kappa B; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; RNA, Messenger; Sepsis | 1996 |
Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
Topics: Acetylcysteine; Animals; Cecum; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Kinetics; Leupeptins; Male; Multienzyme Complexes; Muscle Proteins; Muscle, Skeletal; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sepsis; Transcription, Genetic; Ubiquitins | 1998 |
Protective effect of N-acetylcysteine on cellular energy depletion in a non-septic shock model induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Cell Membrane Permeability; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Macrophages, Peritoneal; Male; NAD; Nitrates; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Tyrosine; Zymosan | 1999 |
Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense.
Topics: Acetylcysteine; Animals; Cell Movement; Chemokines; Glutathione; Immunity, Innate; Inflammation; Male; Mice; Mice, Inbred ICR; Neutrophils; Sepsis | 2002 |
Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice.
Topics: Acetylcysteine; Animals; Endotoxins; Escherichia coli; Female; Free Radicals; Mice; Mice, Inbred Strains; Sepsis; Superoxide Dismutase | 1988 |